-
1 Comment
Visiomed Group SA is currently in a long term downtrend where the price is trading 65.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Based on the above factors, Visiomed Group SA gets an overall score of 1/5.
| Exchange | PA |
|---|---|
| CurrencyCode | EUR |
| ISIN | FR0013481835 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | 53M |
|---|---|
| Beta | -0.62 |
| PE Ratio | 0.0 |
| Target Price | 0.7 |
| Dividend Yield | None |
Visiomed Group SA, together with its subsidiaries, provides healthcare technology and services in France and internationally. It offers BewellConnect, an eco-system of health solutions including enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; and Smart Salem, a medical fitness screening device. Visiomed Group SA was founded in 2007 and is headquartered in Paris, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALVMG.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
